Literature DB >> 31692038

Impact of modulation of telomerase and cancer stem-cell marker OCT4 axis in cervical cancer pathogenesis with underlying HPV16 infection.

Diptika Tiwari1,2, Chandana Ray Das3,4, Rizwana Sultana2, Shantipriya Kakoti2, Mohammad Aasif Khan5, Anita Dongre5, Syed Akhtar Husain5, Purabi Deka Bose1, Sujoy Bose3.   

Abstract

Lacunae exist in the molecular event(s) specificity associated with cervical cancer (CaCx) pathogenesis. The present study aimed to evaluate the significance of telomerase-cervical cancer stem cells (CSCs) modulation in CaCx pathogenesis with underlying HPV16 infection. The study included HPV16 positive cases only (N = 65) of the total enrolled cases from Northeast India. The analysis of viral load and the differential messenger RNA expression of E6, E7, hTERT, hTR, and cancer stem-cell markers was studied by real-time polymerase chain reaction. Further the protein and colocalization study for E6, hTERT, and oct4 was performed by immunofluorescence. The real-time polymerase chain reaction based analysis showed an upregulation of HPV16 viral oncoprotein E6 and E7, and telomerase component hTERT and hTR expression and their correlation in CaCx susceptibility and severity. The hTERT expression correlated with viral load; while the E6 and telomerase protein expression colocalized in the nucleus. The CSCs marker octamer-binding transcription factor 4 (OCT4) was significantly upregulated in CaCx cases, was associated with CaCx susceptibility and severity, and colocalized with E6 expression in the nucleus as revealed from the immunofluorescence studies. To conclude, the telomerase-OCT4 axis modulation holds key in HPV16 CaCx pathogenesis mediated by HPV16 E6 viral oncoprotein expression, and underlines its potential for therapeutic targeting.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  E6; HPV16; OCT4; cervical cancer; hTERT; viral load

Mesh:

Substances:

Year:  2019        PMID: 31692038     DOI: 10.1002/jcb.29501

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients.

Authors:  Raheleh Roudi; Mahboubeh Barodabi; Zahra Madjd; Giandomenico Roviello; Silvia Paola Corona; Mahshid Panahei
Journal:  Mol Cell Oncol       Date:  2020-07-14

2.  miR-326 inhibits the cell proliferation and cancer stem cell-like property of cervical cancer in vitro and oncogenesis in vivo via targeting TCF4.

Authors:  Jian Zhang; Haining He; Kana Wang; Yao Xie; Zhongmei Yang; Mingrong Qie; Zhi Liao; Zhenrong Zheng
Journal:  Ann Transl Med       Date:  2020-12

3.  HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression via Co-Repressor NCOR1.

Authors:  Shujuan Shu; Zhi Li; Liu Liu; Xia Ying; Yina Zhang; Ting Wang; Xiaoye Zhou; Peiyue Jiang; Weiguo Lv
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.